Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2004.08.051PMID 15705480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.

  2004cited by this paper
• Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings.

  2004cited by this paper
• Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

  2004cited by this paper
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

  2003cited by this paper
• The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine.

  2003cited by this paper
• Evaluation of a PCR Assay for Detection of Streptococcus pneumoniae in Respiratory and Nonrespiratory Samples from Adults with Community-Acquired Pneumonia

  2003cited by this paper
• Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings

  2003cited by this paper
• Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity

  2003cited by this paper
• Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

  2003cited by this paper
• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

  2002cited by this paper
• Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?

  2002cited by this paper
• Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California

  2002cited by this paper
• Pneumococcal carriage in children during their first two years: important role of family exposure

  2001cited by this paper
• Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

  2001cited by this paper
• Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees

  2001cited by this paper
• Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired Pneumonia

  2001cited by this paper
• Initial steps in Streptococcus pneumoniae interaction with and pathogenicity to the host.

  2000cited by this paper
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

  2000cited by this paper
• Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study

  2000cited by this paper
• Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America.

  1999cited by this paper
• Usefulness of PCR and Antigen Latex Agglutination Test with Samples Obtained by Transthoracic Needle Aspiration for Diagnosis of Pneumococcal Pneumonia

  1999cited by this paper
• Infant Hib vaccination and herd immunity.

  1999cited by this paper
• Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.

  1998cited by this paper
• Risk factors for primary invasive pneumococcal disease among children in Finland.

  1995cited by this paper
• In the Mind's Eye: Enhancing Human Performance

  1993cited by this paper
• Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.

  1993cited by this paper
• Herd immunity: history, theory, practice.

  1993cited by this paper
• Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital.

  1985cited by this paper
• Herd immunity: basic concept and relevance to public health immunization practices.

  1971cited by this paper

• Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population

  2023cites this paper
• Cost-effectiveness analysis of pediatric immunization program with 15-valent pneumococcal conjugate vaccine in Japan

  2023cites this paper
• Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a retrospective case-cohort study

  2020cites this paper
• Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study

  2020cites this paper
• Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions.

  2019cites this paper
• Older Human B Cells and Antibodies

  2019cites this paper
• Characterisation and activation of Foxp3+ and Tr1 regulatory T cells in nasopharynx-associated lymphoid tissue by S. pneumoniae

  2019cites this paper
• Pneumococcal disease: a retrospective cohort study on associated factors and risk factors for mortality among hospitalised adults in Singapore

  2019cites this paper
• Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used.

  2017cites this paper
• Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?

  2017cites this paper
• Older Human B Cells and Antibodies

  2017cites this paper
• Economic evaluations in adopting new vaccines in the Finnish national vaccination programme

  2017influential citation
• Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal

  2017cites this paper
• Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea

  2017cites this paper
• Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis

  2017cites this paper
• Economic Analysis of the Link between Advances in Biopharmaceutical Manufacturing and Healthcare Delivery Costs

  2016cites this paper
• ystematic review of incremental non-vaccine cost estimates used in ost-effectiveness analysis on the introduction of rotavirus and neumococcal vaccines

  2016cites this paper
• The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients

  2015cites this paper
• The impact of epidemics of vaccine-preventable disease on vaccine uptake: lessons from the 2011–2012 US pertussis epidemic

  2015cites this paper
• The cost of hospital care for management of invasive group A streptococcal infections in England

  2014cites this paper
• Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children.

  2014cites this paper
• Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

  2014cites this paper
• A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

  2014cites this paper
• The epidemiology and cost-effectiveness of vaccination strategies against infectious diseases

  2013cites this paper
• Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.

  2013cites this paper
• Economic evaluation of universal 7-valent pneumococcal conjugate vaccination in Taiwan: a cost-effectiveness analysis.

  2013cites this paper
• The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong.

  2013cites this paper
• Economic analyses of vaccine policies

  2013cites this paper
• Systematic Review of Drug Administration Costs and Implications for Biopharmaceutical Manufacturing

  2013cites this paper
• Cost–effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions

  2012cites this paper
• Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.

  2012cites this paper
• Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan.

  2012cites this paper
• Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach.

  2012cites this paper
• Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

  2012cites this paper
• Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to the birth cohort in Japan.

  2012cites this paper
• Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.

  2012cites this paper
• Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine.

  2011cites this paper
• Guidelines for the management of adult lower respiratory tract infections ‐ Full version

  2011cites this paper
• Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

  2011cites this paper
• Long-term outcomes of pneumococcal meningitis in childhood and adolescence

  2011cites this paper
• Guidelines for the management of adult lower respiratory tract infections--summary.

  2011cites this paper
• Incorporating external effects in economic evaluation: The case of smoking

  2011cites this paper
• Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar).

  2010cites this paper
• Cost effectiveness of pneumococcal vaccination among Dutch infants: an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

  2010cites this paper
• Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines

  2010cites this paper
• Health economics of infectious diseases

  2009cites this paper
• Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil.

  2009cites this paper
• Economic evaluation of universal infant vaccination with 7vPCV in Hong Kong.

  2009cites this paper
• Health related quality of life in survivors of pneumococcal meningitis

  2009cites this paper
• The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.

  2009cites this paper
• Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

  2009cites this paper
• Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand.

  2009cites this paper
• Pneumococcal conjugate vaccines: what do we know and what do we need?

  2009cites this paper
• Acute bacterial rhinosinusitis and otitis media: Changes in pathogenicity following widespread use of pneumococcal conjugate vaccine

  2008cites this paper
• Pneumococcal conjugate vaccine: review of cost–effectiveness studies in Australia, North America and Europe

  2008cites this paper
• Herd immunity: recent uses in vaccine assessment

  2008cites this paper
• Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis.

  2008cites this paper
• The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

  2008cites this paper
• Pharmacoeconomics of Pneumococcal Conjugate Vaccines

  2008cites this paper
• B-Cells and Antibodies in Old Humans

  2008cites this paper
• Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects

  2008cites this paper
• Three essays on intra -household resource allocation, the cost of illness measure, and immunization policy

  2008cites this paper
• Invasive pneumococcal disease in children in Ireland—the anticipated benefit of conjugate pneumococcal vaccination

  2008cites this paper
• Heptavalent Pneumococcal Conjugate Vaccine: growing knowledge and its implications for Italy.

  2008cites this paper
• Pneumococcal immunisation in the 21st century.

  2008cites this paper
• Streptococcus penumoniae meningitis

  2007cites this paper
• Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).

  2007cites this paper
• Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland.

  2007cites this paper
• Streptococcus penumoniae meningitis. Clinical and experimental studies.

  2007cites this paper
• Streptococcus penumoniae meningitis

  2007cites this paper
• Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

  2007cites this paper
• Are cholera and typhoid vaccines a good investment for a slum in Kolkata, India?

  2007cites this paper
• Acceptance of pneumococcal vaccine under standing orders by race and ethnicity.

  2006cites this paper
• Invasive pneumococcal disease; a serious and preventable infection

  2006cites this paper
• Effects and costs of pneumococcal conjugate vaccination of Belgian children

  2006cites this paper
• Combination conjugate vaccines

  2006cites this paper
• Economics of Rotavirus Gastroenteritis and Vaccination in Europe: What Makes Sense?

  2006cites this paper
• Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.

  2006cites this paper
• Bmc Infectious Diseases the Impact and Effectiveness of Pneumococcal Vaccination in Scotland for Those Aged 65 and over during Winter 2003/2004

  year unknowncites this paper